Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.890
-0.070 (-3.57%)
At close: Jul 13, 2026, 4:00 PM EDT
1.940
+0.050 (2.65%)
Pre-market: Jul 14, 2026, 7:00 AM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $328.07 million as of July 14, 2026. Its market cap has increased by 9,483.78% in one year.
Market Cap
328.07M
Enterprise Value
195.44M
1-Year Change
9,483.78%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $328.07M, an increase of 337.02%. That is a compound annual growth rate of 32.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 328.07M | -6.31% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 364.39M |
| Fate Therapeutics | 361.33M |
| Lyell Immunopharma | 350.24M |
| Foghorn Therapeutics | 349.35M |
| Inhibikase Therapeutics | 347.66M |
| Zentalis Pharmaceuticals | 347.39M |
| OmniAb | 331.99M |
| Immuneering | 330.60M |